Tolerability of four-drug antiretroviral combination therapy in primary HIV-1 infection. (2021)
Attributed to:
Natural Killer Cells as Effectors in HIV Cure Strategies
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/hiv.13118
PubMed Identifier: 33964099
Publication URI: http://europepmc.org/abstract/MED/33964099
Type: Journal Article/Review
Volume: 22
Parent Publication: HIV medicine
Issue: 8
ISSN: 1464-2662